Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CinnoRA vs Humira in Active Rheumatoid Arthritis
NCT03172325Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Nov 2015
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of CinnoRA in rheumatoid arthritis (RA) (2 arms), sponsored by CinnaGen. Primary endpoint: Percentage of Patients With DAS28-EULAR Good and Moderate Responses at 24 weeks. Started Nov 2015; status: completed.
02
Drugs
CinnoRA
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03172325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172325.